Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.2K Buy
345
+25
+8% +$3.28K ﹤0.01% 515
2025
Q4
$43.6K Hold
320
﹤0.01% 499
2025
Q3
$47.2K Hold
320
﹤0.01% 484
2025
Q2
$41.4K Hold
320
﹤0.01% 488
2025
Q1
$38.2K Hold
320
﹤0.01% 487
2024
Q4
$37.1K Hold
320
﹤0.01% 483
2024
Q3
$43.2K Hold
320
﹤0.01% 472
2024
Q2
$43.4K Hold
320
﹤0.01% 468
2024
Q1
$41.4K Hold
320
﹤0.01% 479
2023
Q4
$36.6K Hold
320
﹤0.01% 482
2023
Q3
$29.1K Hold
320
﹤0.01% 498
2023
Q2
$36K Sell
320
-160
-33% -$16.9K ﹤0.01% 492
2023
Q1
$50.3K Sell
480
-320
-40% -$33.4K 0.01% 437
2022
Q4
$88.5K Hold
800
0.01% 354
2022
Q3
$69.9K Hold
800
0.01% 379
2022
Q2
$62.5K Hold
800
0.01% 417
2022
Q1
$68.2K Hold
800
0.01% 418
2021
Q4
$95.9K Hold
800
0.01% 374
2021
Q3
$98.9K Hold
800
0.01% 362
2021
Q2
$96K Hold
800
0.01% 372
2021
Q1
$84.1K Hold
800
0.01% 370
2020
Q4
$81.4K Hold
800
0.01% 359
2020
Q3
$67.3K Hold
800
0.01% 378
2020
Q2
$52K Hold
800
0.01% 403
2020
Q1
$52.1K Hold
800
0.01% 409
2019
Q4
$63K Buy
+800
New +$62.3K 0.01% 424

Other funds holding XYL

Caldwell Trust's XYL Position: Q1 2026 in Review

Caldwell Trust increased its Xylem (XYL) stake by 7.8% in Q1 2026, buying an estimated $3.28K and bringing the position to 345 shares worth $41.2K. The position accounts for ﹤0.01% of the portfolio, ranked #515.

Caldwell Trust first reported a position in XYL in Q4 2019 and has held it in 26 quarters since. The position peaked at $98.9K in Q3 2021. 1,108 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Caldwell Trust held 345 shares of Xylem worth $41.2K as of Q1 2026.
  • Caldwell Trust bought 25 Xylem shares in Q1 2026, an estimated $3.28K.
  • Xylem made up ﹤0.01% of Caldwell Trust's portfolio in Q1 2026, its #515 holding.
  • Caldwell Trust first reported a position in Xylem in Q4 2019 and has held it in 26 quarters since.
  • Caldwell Trust's Xylem position peaked at $98.9K in Q3 2021.
  • 1,108 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Caldwell Trust's 13F filing for Q1 2026, filed 22 Apr 2026.